Zannad Zannad F F Ferreira Ferreira JP JP Pocock Pocock SJ SJ SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials Lancet Lancet 2020 2020 96 96 819 819 829 829 10.1016/S0140-6736(20)31824-9 10.1016/S0140-6736(20)31824-9. The gene discussed is SLC5A2; the disease is heart failure.